Brimonidine Tartrate Solution/ Drops
Product Images NDC 42571-462

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Brimonidine Tartrate (NDC 42571-462). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Micro Labs Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Brimo-crtn.jpg (Brimo Crtn)

This is a description of a pharmaceutical product - Brimonidine Tartrate Ophthalmic Solution - indicated for eye use only. It contains active ingredients like Brimonidine tartrate USP 0.1% and various inactive components such as boric acid, calcium chloride, magnesium chloride, potassium chloride, and others. The recommended usual dosage is one drop three times daily on the affected eye(s). The solution should be stored at a temperature between 15° and 25°C and the bottle is filled to half capacity. The product is manufactured by Micro Labs Limited in India for Micro Labs USA, Inc. It is available in a 5mL container and is sterile.*

FDA Label Image

Brimo-lbl.jpg (Brimo Lbl)

This text provides information about an ophthalmic solution with NDC 42571-462-92 intended for eye use. The usual dosage is one drop three times daily to the affected eye(s). It should be stored at 15° to 25°C (59 to 77°F). The note indicates that the bottle is filled to half capacity. The product is manufactured by Micro Labs USA, Inc. in India.*

FDA Label Image

Brimo-str.jpg (Brimo Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.